Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
September 21, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the speaker lineup for its inaugural...
Absci to Host R&D Day on October 4, 2023
September 06, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will host its first R&D Day...
Absci to Participate in Upcoming Investor Conferences
August 28, 2023 16:05 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
August 14, 2023 08:02 ET
|
Absci Corporation
Entered into partnership with Google Ventures-backed biotech company to discover innovative new medicines Entered into collaboration with Caltech, supported by the Gates Foundation, to discover...
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
August 14, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation, a generative AI drug creation company, announced today that Zach Jonasson, Ph.D., has been appointed Chief Financial Officer...
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
August 10, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced that leading researchers at the California Institute of...
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
August 01, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
June 15, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
June 06, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash., June 06, 2023 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a generative AI drug creation company, today announced the appointment of Frans van Houten to its Board of Directors. With...